The allergic rhinitis segment held the largest share of the market in 2019. Moreover, the market for this segment is anticipated to grow at a signific

The Europe allergy immunotherapies market was valued at US$ 544. 14 million in 2019 and is projected to reach US$ 1,228. 14 million by 2027; it is expected to grow at a CAGR of 10. 8% during 2020–2027.New York, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Report